Cargando…

The use of prophylactic anticonvulsants in patients with brain tumours—a systematic review

QUESTIONS: Should patients with newly diagnosed brain tumours receive prophylactic anticonvulsants to reduce seizure risk? What is the best practice for patients with brain tumours who are taking anticonvulsant medications but who have never had a seizure? PERSPECTIVES: Patients with primary or meta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perry, J., Zinman, L., Chambers, A., Spithoff, K., Lloyd, N., Laperriere, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Multimed Inc. 2006
Materias:	Practice Guideline Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394608/ https://www.ncbi.nlm.nih.gov/pubmed/22792022

Ejemplares similares

Gliadel wafers in the treatment of malignant glioma: a systematic review
por: Perry, J., et al.
Publicado: (2007)

Management of single brain metastasis: a practice guideline
por: Mintz, A., et al.
Publicado: (2007)

Canadian recommendations for the treatment of glioblastoma multiforme
por: Mason, W.P., et al.
Publicado: (2007)

Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline
por: Reece, D., et al.
Publicado: (2006)

Treatment of depression in cancer patients
por: Rodin, G., et al.
Publicado: (2007)

Guidelines for the diagnosis and management of carcinoid tumours. Part 1: The gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group
por: Maroun, J., et al.
Publicado: (2006)

Preparation with recombinant humanized thyroid-stimulating hormone before radioiodine ablation after thyroidectomy: a systematic review
por: Yoo, J., et al.
Publicado: (2009)

Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000
por: Basuyau, J P, et al.
Publicado: (2003)

Management of skin rash during egfr-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations
por: Melosky, B., et al.
Publicado: (2009)

Optimal use of taxanes in metastatic breast cancer
por: King, K.M., et al.
Publicado: (2009)

Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer
por: Hanna, W., et al.
Publicado: (2007)

A framework for the organization and delivery of systemic treatment
por: Vandenberg, T., et al.
Publicado: (2009)

The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statement
por: Ellis, P.M., et al.
Publicado: (2009)

Biochemotherapy for the treatment of metastatic malignant melanoma: a clinical practice guideline
por: Verma, S., et al.
Publicado: (2008)

Temozolomide for the treatment of metastatic melanoma
por: Quirbt, I., et al.
Publicado: (2007)

Alemtuzumab in chronic lymphocytic leukemia
por: Fraser, G., et al.
Publicado: (2007)

Adjuvant hormonal therapy for stage I endometrial cancer
por: Gien, L., et al.
Publicado: (2008)

Single-agent interleukin-2 in the treatment of metastatic melanoma
por: Petrella, T., et al.
Publicado: (2007)

(131)I–Tositumomab in lymphoma
por: Cheung, M.C., et al.
Publicado: (2009)

The role of her2-targeted therapies in women with her2-overexpressing metastatic breast cancer
por: Dent, S., et al.
Publicado: (2009)

The role of neoadjuvant her2-targeted therapies in her2-overexpressing breast cancers
por: Lemieux, J., et al.
Publicado: (2009)

Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria
por: Margalit, Danielle N., et al.
Publicado: (2020)

Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer
por: Jonker, D., et al.
Publicado: (2006)

Canadian supportive care recommendations for the management of neutropenia in patients with cancer
por: Kouroukis, C.T., et al.
Publicado: (2008)

Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group
por: Mackey, J.R., et al.
Publicado: (2008)

Optimal chemotherapy treatment for women with recurrent ovarian cancer
por: Fung-Kee-Fung, M., et al.
Publicado: (2007)

Canadian supportive care recommendations for the management of anemia in patients with cancer
por: Mikhael, J., et al.
Publicado: (2007)

Cancer antigen 125 in ovarian cancer surveillance: a decision analysis model
por: Hopkins, M.L., et al.
Publicado: (2007)

Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline
por: Verma, S., et al.
Publicado: (2008)

Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline
por: Verma, S., et al.
Publicado: (2007)

Colorectal Cancer Association of Canada consensus meeting: raising the standards of care for early-stage rectal cancer
Publicado: (2009)

Clinician–patient communication: evidence-based recommendations to guide practice in cancer
por: Rodin, G., et al.
Publicado: (2009)

The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline
por: Mikkelsen, Tom, et al.
Publicado: (2009)

Cost effectiveness of tac versus fac in adjuvant treatment of node-positive breast cancer
por: Mittmann, N., et al.
Publicado: (2010)

Summary version of the Standards, Options and Recommendations for the use of analgesia for the treatment of nociceptive pain in adults with cancer (update 2002)
por: Krakowski, I, et al.
Publicado: (2003)

Tumour assessment and staging: United Kingdom National Multidisciplinary Guidelines
por: Roland, N, et al.
Publicado: (2016)

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
por: Ramage, John K, et al.
Publicado: (2011)

Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[(18)F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002)
por: Bourguet, P, et al.
Publicado: (2003)

Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: an Australian perspective
por: Watts, Gerald F., et al.
Publicado: (2021)

Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001)
por: Mauriac, L, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_m1c1q8h2njasf0vjncssccm1g3